Dr Reddy's to recall 1,752 bottles of heartburn drug in the US

The ongoing Class III recall is on account of "Discolouration" and
because the product contains brown pellets, USFDA said. As per the US
health regulator, a class III recall is initiated in a situation "in
which use of or exposure to a violative product is not likely to cause
adverse health consequences".

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-to-recall-1752-bottles-of-heartburn-drug-in-the-us/articleshow/75656114.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment